Variant report
Variant | esv3349298 |
---|---|
Chromosome Location | chr2:76358346-76378794 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535015680 | chr2:76364022-76364023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369467727 | chr2:76364025-76364026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71420904 | chr2:76364051-76364052 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs7585603 | chr2:76364064-76364065 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs573552179 | chr2:76364069-76364070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535475891 | chr2:76364071-76364072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146202140 | chr2:76364091-76364092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575703069 | chr2:76364095-76364096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539247359 | chr2:76364096-76364097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557977453 | chr2:76364113-76364114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs193283118 | chr2:76364127-76364128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540500862 | chr2:76364135-76364136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561986351 | chr2:76364147-76364148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs137946772 | chr2:76364158-76364159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544236314 | chr2:76364162-76364163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562436796 | chr2:76364213-76364214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184293554 | chr2:76364300-76364301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs540972259 | chr2:76364314-76364315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552476125 | chr2:76364322-76364323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149451228 | chr2:76364333-76364334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7568627 | chr2:76364362-76364363 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs546859765 | chr2:76364394-76364395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568415671 | chr2:76364404-76364405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368830198 | chr2:76364423-76364424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148687415 | chr2:76364430-76364431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7582596 | chr2:76364444-76364445 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs569248750 | chr2:76364457-76364458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147432635 | chr2:76364472-76364473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557988224 | chr2:76364483-76364484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566644809 | chr2:76364504-76364505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs4640412 | chr2:76364514-76364515 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs374237593 | chr2:76364536-76364537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138357636 | chr2:76366245-76366246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113394496 | chr2:76366246-76366247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12993689 | chr2:76366272-76366273 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs13020068 | chr2:76366346-76366347 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs147422740 | chr2:76366368-76366369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs578187458 | chr2:76366373-76366374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs189864676 | chr2:76366396-76366397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538803334 | chr2:76366397-76366398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376137136 | chr2:76366405-76366406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12994329 | chr2:76366442-76366443 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs534482868 | chr2:76366457-76366458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12994139 | chr2:76366489-76366490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs562540478 | chr2:76366506-76366507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147201725 | chr2:76366541-76366542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1608591 | chr2:76366574-76366575 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs564966405 | chr2:76366575-76366576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182530134 | chr2:76366593-76366594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs148531732 | chr2:76366607-76366608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76364000-76364600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr2:76366200-76367200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |